アンレキサノクス(68302-57-8)

ChemicalBook Optimization Suppliers
名前: Jinan Zhongke Yitong Chemical Co., Ltd.  Gold
電話番号: 0531-88658009
電子メール: lxxcs@163.com
名前: Shandong Zhongke Taidou Chemical Co., Ltd.  Gold
電話番号: 0531-88682302 18615650139
電子メール: 3303447386@qq.com
名前: J & K SCIENTIFIC LTD.  
電話番号: 010-82848833 400-666-7788
電子メール: jkinfo@jkchemical.com
名前: TCI (Shanghai) Development Co., Ltd.  
電話番号: 021-67121386
電子メール: Sales-CN@TCIchemicals.com
名前: BeiJing Hwrk Chemicals Limted  
電話番号: 0757-86329057 18934348241
電子メール: sales4.gd@hwrkchemical.com
アンレキサノクス 製品概要
化学名:アンレキサノクス
英語化学名:Amlexanox
别名:5h-(1)benzopyrano(2,3-b)pyridine-3-carboxylicacid,2-amino-7-(1-methylethyl)-5;aa-673;amoxanox;RARECHEM AL BO 1376;AMLEXANOX;2-Amino-7-(1-methylethyl)-5-oxo-5H-[1]benzopyrano[2,3-b J pyridine-3-carboxylic acid;CHX-3673;Elics
CAS番号:68302-57-8
分子式:C16H14N2O4
分子量:298.29
EINECS:804-135-3
カテゴリ情報:Intermediates & Fine Chemicals;Pharmaceuticals;Antiallergic;Antiasthmatic
Mol File:68302-57-8.mol
アンレキサノクス
アンレキサノクス 物理性質
融点 >3000C
沸点 570.0±50.0 °C(Predicted)
比重(密度) 1.408±0.06 g/cm3(Predicted)
貯蔵温度 -20°C
溶解性DMSO: soluble10mg/mL at warmed, clear
酸解離定数(Pka)3.95±0.20(Predicted)
外見 powder
white to beige
Merck 14,490
安定性:Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
CAS データベース68302-57-8(CAS DataBase Reference)
安全性情報
主な危険性 Xn
Rフレーズ 22-43
Sフレーズ 36/37-37-36
WGK Germany 3
RTECS 番号DJ3102000
HSコード 29349990
アンレキサノクス Usage And Synthesis
外観白色~うすい黄色粉末~結晶
効能抗アレルギー薬, メディエーター遊離抑制薬
商品名エリックス (千寿製薬)
説明Amlexanox is an orally-active antiasthmatic agent useful in the treatment of bronchial asthma and allergy-related sinus disorders. The therapeutic effect of amlexanox appears to be attributed to its inhibitory actions on leukohiene D4, PAF and histamine.
化学的特性White Crystalline Solid
OriginatorTakeda (Japan)
使用Inhibits release of allergic mediators from mast cells. Antiallergic; antiasthmatic
定義ChEBI: A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
Manufacturing ProcessA mixture of 2 ml of morpholine, 3 ml of dimethylformamide and 10 ml of water was heated to 60°C and under stirring the equal molecular quantity of 6-isopropyl-4-oxo-4H-1-benzopyran-3-carbonitrile was added for 5 minutes. The mixture was heated at that temperature for one hour and the resultant precipitate was filtered, rained with water recrystallized from acetic acid and washed with chloroform. By the above procedure was obtained 2-amino-6- isopropyl-4-oxo-4H-1-benzopyran-3-carboxaldehyde melting at 206°-208°C. A mixture of 4 ml ethyl cyanoacetate, 50 ml of ethanol, 5 ml of piperidine and the equal molecular quantity of 2-amino-6-isopropyl-4-oxo-4H-1-benzopyran- 3-carboxaldehyde was refluxed for 30 minutes and, after cooling, the crystalline precipitate was filtered and washed with chloroform. By above procedure was obtained ethyl-2-amino-7-isopropyl-1-azaxanthone-3- carboxylate, melting after recrystallization from ethanol at 243°-244°C. A mixture of 10 ml of acetic acid and 10 ml of 55% sulfuric acid the equal molecular quantity and 2-ethyl-amino-7-isopropyl-1-azaxanthone-3- carboxylate was stirred at 130°C for 4 hours and, after water was added, the precipitate was collected by filtration and recrystalllized from dimethylformamide to give the 2-amino-7-(1-methylethyl)-5-oxo-5H- [1]benzopyrano[2,3-b]pyridine-3-carboxylic acid, melting point 300°C.
brand nameAphthasol (Uluru);Solfa.
Therapeutic FunctionAntiulcer (topical)
一般的な説明Amlexanox is an anti-allergic drug with anti-inflammatory properties.
Biochem/physiol ActionsAmlexanox elevates the amount of nonsense-containing mRNAs in treated cells and helps to generate full-length proteins effectively.
貯蔵Store at -20°C
参考文献1) Koch et al. (2013), Obesity: Teaching an old drug new tricks – amlexanox targets inflammation to improve metabolic dysfunction; Nat. Rev. Endocrinol., 9 185 2) Reilly et al. (2013), An inhibitor of the protein kinases TBK1 and IKK-ε improves obesity-related metabolic dysfunctions in mice; Nat. Med., 19 313 3) Nasry et al. (2016), Different modalities for treatment of recurrent aphthous stromatitis. A Randomized clinical trial; J. Clin. Exp. Dent. 8 e517 4) Cheng et al. (2018), Aphthous ulcer drug inhibits prostate tumor metastasis by targeting IKKε/TBK1/NFκB signaling; Theranostics 8 4633
Tags:68302-57-8